Unknown

Dataset Information

0

Effects of Exendin-4 on human adipose tissue inflammation and ECM remodelling.


ABSTRACT: Subjects with type-2 diabetes are typically obese with dysfunctional adipose tissue (AT). Glucagon-like peptide-1 (GLP-1) analogues are routinely used to improve glycaemia. Although, they also aid weight loss that improves AT function, their direct effect on AT function is unclear. To explore GLP-1 analogues' influence on human AT's cytokine and extracellular matrix (ECM) regulation, we therefore obtained and treated omental (OMAT) and subcutaneous (SCAT) AT samples with Exendin-4, an agonist of the GLP-1 receptor (GLP-1R).OMAT and abdominal SCAT samples obtained from women during elective surgery at the Royal Devon & Exeter Hospital (UK) were treated with increasing doses of Exendin-4. Changes in RNA expression of adipokines, inflammatory cytokines, ECM components and their regulators were assessed and protein secretion analysed by ELISA. GLP-1R protein accumulation was compared in paired AT depot samples.Exendin-4 induced an increase in OMAT adiponectin (P=0.02) and decrease in elastin expression (P=0.03) in parallel with reduced elastin secretion (P=0.04). In contrast to OMAT, we did not observe an effect on SCAT. There was no change in the expression of inflammatory markers (CD14, TNFA, MCP-1), collagens, TGFB1 or CTGF. GLP-1R accumulation was higher in SCAT.Independently of weight loss, which may bias findings of in vivo studies, GLP-1 analogues modify human OMAT physiology favourably by increasing the insulin-sensitising cytokine adiponectin. However, the reduction of elastin and no apparent effect on AT's inflammatory cytokines suggest that GLP-1 analogues may be less beneficial to AT function, especially if there is no associated weight loss.

SUBMITTER: Pastel E 

PROVIDER: S-EPMC5223133 | biostudies-other | 2016 Dec

REPOSITORIES: biostudies-other

altmetric image

Publications

Effects of Exendin-4 on human adipose tissue inflammation and ECM remodelling.

Pastel E E   Joshi S S   Knight B B   Liversedge N N   Ward R R   Kos K K  

Nutrition & diabetes 20161212 12


<h4>Background/objectives</h4>Subjects with type-2 diabetes are typically obese with dysfunctional adipose tissue (AT). Glucagon-like peptide-1 (GLP-1) analogues are routinely used to improve glycaemia. Although, they also aid weight loss that improves AT function, their direct effect on AT function is unclear. To explore GLP-1 analogues' influence on human AT's cytokine and extracellular matrix (ECM) regulation, we therefore obtained and treated omental (OMAT) and subcutaneous (SCAT) AT samples  ...[more]

Similar Datasets

| S-EPMC7230369 | biostudies-literature
| S-EPMC9561982 | biostudies-literature
| S-EPMC10561428 | biostudies-literature
| S-EPMC2959201 | biostudies-literature
| S-EPMC4344953 | biostudies-literature
| S-EPMC8648771 | biostudies-literature
| S-EPMC5928436 | biostudies-literature
| S-EPMC7554650 | biostudies-literature
| S-EPMC6290757 | biostudies-literature
| S-EPMC5770450 | biostudies-literature